According to a new study, by the Harvey L. Neiman Health Policy Institute and the American College of Radiology’s National Mammography Database Committee, the most influential radiologist characteristics impacting mammography interpretive performance were geography, breast sub-specialization, performance of diagnostic mammography, and performance of diagnostic ultrasound.

Getty Images


June 23, 2021 — According to a new study by the Harvey L. Neiman Health Policy Institute and the American College of Radiology’s National Mammography Database Committee, the most influential radiologist characteristics impacting mammography interpretive performance were geography, breast sub-specialization, performance of diagnostic mammography, and performance of diagnostic ultrasound.

Published June 22 in Radiology, the study analyzed 11 years of screening mammography performance metrics from the National Mammography Database (NMD). From this dataset, researchers found that radiologists in the West or Midwest, breast subspecialists, and those who perform diagnostic mammography were more likely to achieve acceptable performance across a range of metrics. Those who perform breast ultrasound were less likely to achieve acceptable performance across metrics.

Researchers say that despite wide variation across radiologists in the accuracy of mammographic interpretation, factors that predict performance are poorly understood.

“It was interesting that in many cases certain characteristics predicted higher performance in some areas and, at the same time, lower performance on others,” said first author Cindy Lee, MD, FACMQ, FSBI, Assistant Professor of Radiology at NYU Grossman School of Medicine. For example, radiologists who are in academic practice, are breast imagers, and with more years in practice are more likely to have higher recall rates, but they are also more likely to detect higher proportions of ductal carcinoma in situ, have higher cancer detection rates, and higher invasive cancer detection rates — critical measures for reducing breast cancer mortality. “This example highlights the importance of assessing performance across measures holistically versus individual metrics in isolation, supporting guidance in the ACR BI-RADS atlas” Dr. Lee explained.

This study has the largest sample of radiologists with verified demographic and workforce data and interpretive screening performance in the United States. Of the 1,223 radiologists studied, 31.7% of radiologists had acceptable performance for all metrics, based on external benchmarks. For each metrics individually, 52-77% of radiologists demonstrated performance in the acceptable range. 

“Most mammograms performed in the United States are interpreted by general radiologists and not by breast subspecialty radiologists, who account for less than 10% of all radiologists,” said Andrew Rosenkrantz, MD, MPA, lead study author, professor and director of health policy in the Department of Radiology at NYU Grossman School of Medicine and a Neiman Institute senior affiliate research fellow. “As the U.S. population ages and greater numbers of women comply with screening guidelines, the demand for all radiologists to interpret screening mammograms is anticipated to increase. Hence, attention to the interpretive screening performance of all radiologists is critical, and strategies to improve interpretive accuracy among generalists would be beneficial.”

For more information: www.neimanhpi.org


Related Content

News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group—lead by authors at the University of Toronto—have developed an approach for ...

Time April 23, 2024
arrow
News | FDA

April 23, 2024 — Royal Philips , a global leader in health technology, today announced its Philips Zenition 30 mobile C ...

Time April 23, 2024
arrow
News | Ultrasound Imaging

April 22, 2024 — GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which ...

Time April 22, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Subscribe Now